Age-Related Metabolic Profiles in Cognitively Healthy Elders: Results from a Voxel-Based [(18)F]Fluorodeoxyglucose-Positron-Emission Tomography Study with Partial Volume Effects Correction


Autoria(s): CURIATI, P. K.; TAMASHIRO-DURAN, J. H.; DURAN, F. L. S.; BUCHPIGUEL, C. A.; SQUARZONI, P.; ROMANO, D. C.; VALLADA, H.; MENEZES, P. R.; SCAZUFCA, M.; BUSATTO, G. F.; ALVES, T. C. T. F.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

BACKGROUND AND PURPOSE: Functional brain variability has been scarcely investigated in cognitively healthy elderly subjects, and it is currently debated whether previous findings of regional metabolic variability are artifacts associated with brain atrophy. The primary purpose of this study was to test whether there is regional cerebral age-related hypometabolism specifically in later stages of life. MATERIALS AND METHODS: MR imaging and FDG-PET data were acquired from 55 cognitively healthy elderly subjects, and voxel-based linear correlations between age and GM volume or regional cerebral metabolism were conducted by using SPM5 in images with and without correction for PVE. To investigate sex-specific differences in the pattern of brain aging, we repeated the above voxelwise calculations after dividing our sample by sex. RESULTS: Our analysis revealed 2 large clusters of age-related metabolic decrease in the overall sample, 1 in the left orbitofrontal cortex and the other in the right temporolimbic region, encompassing the hippocampus, the parahippocampal gyrus, and the amygdala. The division of our sample by sex revealed significant sex-specific age-related metabolic decrease in the left temporolimbic region of men and in the left dorsolateral frontal cortex of women. When we applied atrophy correction to our PET data, none of the above-mentioned correlations remained significant. CONCLUSIONS: Our findings suggest that age-related functional brain variability in cognitively healthy elderly individuals is largely secondary to the degree of regional brain atrophy, and the findings provide support to the notion that appropriate PVE correction is a key tool in neuroimaging investigations.

Wellcome Trust, UK[GR066133MA]

FAPESP Fundacao Amparo a Pequisa Estado Sao Paulo, Brazil[04/15336-5]

FAPESP Fundacao Amparo a Pequisa Estado Sao Paulo, Brazil[04/12694-8]

FAPESP Fundacao Amparo a Pequisa Estado Sao Paulo, Brazil[06/04405-1]

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil

Identificador

AMERICAN JOURNAL OF NEURORADIOLOGY, v.32, n.3, p.560-565, 2011

0195-6108

http://producao.usp.br/handle/BDPI/22842

10.3174/ajnr.A2321

http://dx.doi.org/10.3174/ajnr.A2321

Idioma(s)

eng

Publicador

AMER SOC NEURORADIOLOGY

Relação

American Journal of Neuroradiology

Direitos

restrictedAccess

Copyright AMER SOC NEURORADIOLOGY

Palavras-Chave #POSITRON-EMISSION-TOMOGRAPHY #CEREBRAL GLUCOSE-METABOLISM #ALZHEIMERS-DISEASE #HUMAN-BRAIN #MATTER VOLUME #SAO-PAULO #FDG PET #ATROPHY #HYPOMETABOLISM #REGISTRATION #Clinical Neurology #Neuroimaging #Radiology, Nuclear Medicine & Medical Imaging
Tipo

article

original article

publishedVersion